Scientists used CRISPR to reactivate uricase, an enzyme humans lost millions of years ago. Restoring the gene in liver cells ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

Another major buy was in INTELLIA THERAPEUTICS INC (NASDAQ:NTLA), with ARK purchasing 191,705 shares for around $2.18 million through its ARKK ETF. Similar to CRISPR, INTELLIA has seen increased ...

Healthcare: A Paradigm Revolution from 'Curing' to 'Preventive Health' AI is driving the healthcare system from passive treatment to proactive health management. In the field of disease prediction, ...

The company is now involved in a new project in Winston-Salem. It’s establishing the BioSpherix Center for Cytocentric ...

From powerful quantum processors to green energy breakthroughs, these technologies are not isolated advances; they are ...

Unprecedented growth at a CAGR of 39.6% positions CAR T-cell therapy as a transformative force in oncologyDelray Beach, FL, ...

Raleigh sustainable food startup Atlantic Fish Co. has received a $305,000 Small Business Innovation Research (SBIR) grant ...

A lab-made diet sparked a 15-fold boom in bee reproduction, pointing to a possible solution for collapsing colonies.

Single-celled species that often stick together in colonies have researchers rethinking the origin of animals.

Hypoxia-inducible factors (HIFs), ETS-1, MYC, and β-catenin act as master regulators that constitutively activate oncogenic ...

Market Outlook According to Credence Research, the CAR-T Cell Therapy Market is set to witness robust growth, advancing from ...